Kura Oncology Logo
Kura Oncology Announces Data Presentation on Lead Product Candidate Tipifarnib at the Upcoming ASH Meeting
December 03, 2015 07:00 ET | Kura Oncology, Inc.
LA JOLLA, Calif., Dec. 3, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical stage biopharmaceutical company, today announced that new data from a Phase 3 trial of tipifarnib, the...
Kura Oncology Logo
Kura Oncology to Present at the Oppenheimer 2015 Healthcare Conference
December 01, 2015 07:00 ET | Kura Oncology, Inc.
LA JOLLA, Calif., Dec. 1, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical stage biopharmaceutical company, today announced that Troy Wilson, Ph.D., J.D., President and Chief...
Kura Oncology Logo
Kura Oncology to Present at Upcoming Investor Conference
November 30, 2015 18:40 ET | Kura Oncology, Inc.
LA JOLLA, Calif., Nov. 30, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ:KURA), a clinical stage biopharmaceutical company, today announced that Troy Wilson, Ph.D., J.D., President and Chief...
Kura Oncology Logo
Kura Oncology Announces First Patient Dosed in an Investigator-Sponsored Phase 2 Trial of Tipifarnib in Patients With HRAS Mutant Urothelial Cancer
November 30, 2015 07:00 ET | Kura Oncology, Inc.
LA JOLLA, Calif., Nov. 30, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ:KURA), today announced that the first patient has been dosed in an investigator-sponsored Phase 2 trial of its lead drug...
Kura Oncology Logo
Kura Oncology Announces Pricing of Public Offering of Common Stock
November 04, 2015 18:09 ET | Kura Oncology, Inc.
LA JOLLA, Calif., Nov. 4, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc., a clinical stage biopharmaceutical company advancing a pipeline of precision medicines for the treatment of solid tumors and...
Kura Oncology Logo
Kura Oncology Announces Launch of Public Offering of Common Stock
October 28, 2015 17:05 ET | Kura Oncology, Inc.
LA JOLLA, Calif., Oct. 28, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (OTCQB:KURO), a clinical stage biopharmaceutical company advancing a pipeline of precision medicines for the treatment of solid...
Kura Oncology Logo
Kura Oncology Initiates Phase 2 Study of Tipifarnib in Peripheral T-cell Lymphoma
September 30, 2015 07:30 ET | Kura Oncology, Inc.
LA JOLLA, Calif., Sept. 30, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (OTCQB:KURO), a clinical stage biopharmaceutical company advancing a pipeline of precision medicines for the treatment of solid...
Kura Oncology Logo
Kura Oncology to Present at the 2015 Wedbush PacGrow Healthcare Conference
August 05, 2015 07:30 ET | Kura Oncology, Inc.
LA JOLLA, Calif., Aug. 5, 2015 (GLOBE NEWSWIRE) -- Kura Oncology, Inc., a clinical stage biopharmaceutical company advancing a pipeline of precision medicines for the treatment of solid tumors and...